Topical CBD gel shows promising activity in hard-to-treat epilepsies

Cannabidiol (CBD) transdermal gel is safe, well tolerated, and associated with reductions in seizure frequency and disease burden in children and adolescents with developmental and epileptic encephalopathies (DEEs). An Australian and New Zealand study, published in JAMA Network Open, comprised 48 patients 3-18 years of age with a wide range of DEE syndromes and aetiologies ...

Already a member?

Login to keep reading.

© 2021 the limbic